0001209191-15-048302.txt : 20150601
0001209191-15-048302.hdr.sgml : 20150601
20150601160959
ACCESSION NUMBER: 0001209191-15-048302
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150528
FILED AS OF DATE: 20150601
DATE AS OF CHANGE: 20150601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Viking Therapeutics, Inc.
CENTRAL INDEX KEY: 0001607678
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461073877
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD, SUITE 50
CITY: SAN DIEGO
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-550-7810
MAIL ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD, SUITE 50
CITY: SAN DIEGO
STATE: CA
ZIP: 92037
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37355
FILM NUMBER: 15903480
BUSINESS ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-28
0
0001607678
Viking Therapeutics, Inc.
VKTX
0000886163
LIGAND PHARMACEUTICALS INC
11119 NORTH TORREY PINES ROAD, SUITE 200
LA JOLLA
CA
92037
0
0
1
0
Common Stock
2015-05-28
4
J
0
228105
0.00
A
4780964
D
The shares of Common Stock were acquired as partial consideration for licenses granted to the Issuer by Ligand Pharmaceuticals Incorporated ("Ligand") pursuant to the Master License Agreement, dated May 21, 2014, among Ligand, Metabasis Therapeutics, Inc. ("Metabasis"), a wholly-owned subsidiary of Ligand, and the Issuer, as amended by the First Amendment to Master License Agreement, dated September 6, 2014 and the Second Amendment to Master License Agreement, dated April 8, 2015.
Includes 55,060 shares acquired by Metabasis.
Includes 882,474 shares held by Metabasis.
/s/ Charles S. Berkman
2015-06-01